AIM: To compare 2% econazole and 5% natamycin in the management of fungal keratitis. METHODS: A randomised clinical trial was performed using 2% econazole or 5% natamycin as the two treatment arms on patients presenting with culture positive fungal keratitis to the cornea service at Aravind Eye Care System, Madurai, India. RESULTS:116 patients were recruited, and 112 continued in the study. There were no significant differences between the two arms at baseline or for success (defined as a healed or healing ulcer) at final visit (p = 0.79). CONCLUSIONS: 2% Econazole appears to be as effective as 5% natamycin for the management of fungal keratitis.
RCT Entities:
AIM: To compare 2% econazole and 5% natamycin in the management of fungal keratitis. METHODS: A randomised clinical trial was performed using 2% econazole or 5% natamycin as the two treatment arms on patients presenting with culture positive fungal keratitis to the cornea service at Aravind Eye Care System, Madurai, India. RESULTS: 116 patients were recruited, and 112 continued in the study. There were no significant differences between the two arms at baseline or for success (defined as a healed or healing ulcer) at final visit (p = 0.79). CONCLUSIONS: 2% Econazole appears to be as effective as 5% natamycin for the management of fungal keratitis.
Authors: L B Brilliant; R P Pokhrel; N C Grasset; J M Lepkowski; A Kolstad; W Hawks; R Pararajasegaram; G E Brilliant; S Gilbert; S R Shrestha Journal: Bull World Health Organ Date: 1985 Impact factor: 9.408
Authors: M P Upadhyay; P C Karmacharya; S Koirala; N R Tuladhar; L E Bryan; G Smolin; J P Whitcher Journal: Am J Ophthalmol Date: 1991-01-15 Impact factor: 5.258
Authors: M C Chirambo; J M Tielsch; K P West; J Katz; T Tizazu; L Schwab; G Johnson; J Swartwood; H R Taylor; A Sommer Journal: Bull World Health Organ Date: 1986 Impact factor: 9.408
Authors: Namperumalsamy V Prajna; Jeena Mascarenhas; Tiruvengada Krishnan; P Ravindranath Reddy; Lalitha Prajna; Muthiah Srinivasan; C M Vaitilingam; Kevin C Hong; Salena M Lee; Stephen D McLeod; Michael E Zegans; Travis C Porco; Thomas M Lietman; Nisha R Acharya Journal: Arch Ophthalmol Date: 2010-06
Authors: Joseph B Ciolino; Sarah P Hudson; Ashley N Mobbs; Todd R Hoare; Naomi G Iwata; Gerald R Fink; Daniel S Kohane Journal: Invest Ophthalmol Vis Sci Date: 2011-08-09 Impact factor: 4.799